DK135588A - Inaktivering af hiv i proteinholdige oploesninger ved hjaelp af phenoler - Google Patents

Inaktivering af hiv i proteinholdige oploesninger ved hjaelp af phenoler

Info

Publication number
DK135588A
DK135588A DK135588A DK135588A DK135588A DK 135588 A DK135588 A DK 135588A DK 135588 A DK135588 A DK 135588A DK 135588 A DK135588 A DK 135588A DK 135588 A DK135588 A DK 135588A
Authority
DK
Denmark
Prior art keywords
hiv
inactivation
solutions
proteinal
phenoles
Prior art date
Application number
DK135588A
Other languages
English (en)
Other versions
DK135588D0 (da
Inventor
Joachim Hilfenhaus
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of DK135588D0 publication Critical patent/DK135588D0/da
Publication of DK135588A publication Critical patent/DK135588A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0088—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16061—Methods of inactivation or attenuation
    • C12N2740/16063—Methods of inactivation or attenuation by chemical treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK135588A 1987-03-12 1988-03-11 Inaktivering af hiv i proteinholdige oploesninger ved hjaelp af phenoler DK135588A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873707987 DE3707987A1 (de) 1987-03-12 1987-03-12 Inaktivierung von human immunodeficiency virus (hiv) in proteinhaltigen loesungen durch phenole

Publications (2)

Publication Number Publication Date
DK135588D0 DK135588D0 (da) 1988-03-11
DK135588A true DK135588A (da) 1988-09-13

Family

ID=6322881

Family Applications (1)

Application Number Title Priority Date Filing Date
DK135588A DK135588A (da) 1987-03-12 1988-03-11 Inaktivering af hiv i proteinholdige oploesninger ved hjaelp af phenoler

Country Status (13)

Country Link
US (1) US4886779A (da)
EP (1) EP0281978B1 (da)
JP (1) JPH07106985B2 (da)
AT (1) ATE88752T1 (da)
AU (1) AU613603B2 (da)
CA (1) CA1340414C (da)
DE (2) DE3707987A1 (da)
DK (1) DK135588A (da)
ES (1) ES2054719T3 (da)
FI (1) FI881123A (da)
IE (1) IE61439B1 (da)
MX (1) MX164795B (da)
ZA (1) ZA881756B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6022742A (en) 1986-11-26 2000-02-08 Kopf; Henry B. Culture device and method
FR2662353A1 (fr) * 1990-05-22 1991-11-29 Neyroud Andre Savon en pain ou liquide antiseptique puissant, qui detruit les virus du sida, assure l'hygiene corporelle et protege la peau.
GB9110808D0 (en) * 1991-05-17 1991-07-10 Retroscreen Ltd Aids vaccine and method for its production
DE10112617A1 (de) * 2001-03-14 2002-10-02 Aventis Behring Gmbh Verwendung eines C1-Esterase-Inhibitors zur Verhinderung oder Verzögerung der Abstoßung von Xenotransplantaten in Säugetieren
CA2832665C (en) * 2011-04-08 2020-01-21 Universidad De Costa Rica Method for producing injectable formulations of blood-derived protein materials, and materials obtained using said method

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL63957C (da) * 1946-01-03
DE2643213C2 (de) * 1976-09-25 1985-02-21 Bayer Ag, 5090 Leverkusen Verfahren zum Abschwächen oder Inaktivieren von Mikroorganismen
US4746508A (en) * 1983-06-06 1988-05-24 Beth Israel Hospital Assn. Drug administration
US4713240A (en) * 1985-04-04 1987-12-15 Research Corporation Vaccines based on insoluble supports
US4673733A (en) * 1985-04-11 1987-06-16 Sudhish Chandra Treatment of biological and pharmaceutical products adsorbed on a solid phase with virus and pyrogen inactivating agents
US4711876A (en) * 1985-12-05 1987-12-08 Catapano Salvatore J Process for the treatment and remission of AIDS (acquired immune deficiency syndrome)
AU1938188A (en) * 1987-06-05 1989-01-04 Habib Al-Sioufi Method and device for disinfecting biological fluids and container for same
US4833165A (en) * 1987-10-07 1989-05-23 Louderback Allan Lee Method of inactivating HTLV-III virus in blood

Also Published As

Publication number Publication date
FI881123A0 (fi) 1988-03-10
ZA881756B (en) 1988-08-31
IE61439B1 (en) 1994-11-02
ES2054719T3 (es) 1994-08-16
EP0281978A2 (de) 1988-09-14
ATE88752T1 (de) 1993-05-15
AU613603B2 (en) 1991-08-08
MX164795B (es) 1992-09-24
EP0281978A3 (en) 1990-01-24
DK135588D0 (da) 1988-03-11
EP0281978B1 (de) 1993-04-28
CA1340414C (en) 1999-03-02
FI881123A (fi) 1988-09-13
US4886779A (en) 1989-12-12
DE3880533D1 (de) 1993-06-03
AU1303788A (en) 1988-09-15
DE3707987A1 (de) 1988-09-22
IE880725L (en) 1988-09-12
JPS63243023A (ja) 1988-10-07
JPH07106985B2 (ja) 1995-11-15

Similar Documents

Publication Publication Date Title
ATE68697T1 (de) Verwendung von azolylmethyloxiranen zur bekaempfung von viralen erkrankungen.
DE3684363D1 (de) Phosphonylmethoxyalkyl-adeninen zur behandlung von viruskrankheiten.
ATE116637T1 (de) Sulfonische stilbenderivate zur behandlung von viruserkrankungen.
ATE165345T1 (de) Sulfonsaeurederivate zur behandlung von viruserkrankungen
DE3780016D1 (de) Pharmazeutisches praeparat mit 3'-desoxythymidin-2'-en(3'-desoxy-2',3'-didehydrothymidin) zur behandlung von patienten mit retroviralen infektionen.
EP0306219A3 (en) Novel hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids
EP0616535A4 (en) PROCESS FOR THE TREATMENT OF VIRAL INFECTIONS.
ATE95564T1 (de) Aeusseres membranprotein f von pseudomonas aeruginosa.
AU2567888A (en) Hiv peptides and methods for detection of hiv
DK135588D0 (da) Inaktivering af hiv i proteinholdige oploesninger ved hjaelp af phenoler
ES2066753T3 (es) Uso de un preparado, que contiene inmunoglobulina, para la profilaxis y la terapia del sida, en personas.
DE3767308D1 (de) Verwendung von sulfonamidderivaten zur herstellung eines antivirusmittels.
DE68924155D1 (de) Verfahren zur herstellung von natürlichem hiv-glykoprotein 160.
EP0323157A3 (en) Antiviral compounds and methods
ES2006632A6 (es) Procedimiento de tratamiento termico de fibrinogeno.
AU7514087A (en) Vaccine containing the protein f of the aids virus
AU2190288A (en) Vector for the expression of proteins of the HIV-2 virus, one of the casual agents of AIDS, cell culture infected or transformed by this vector, proteins obtained, vaccine and antibodies obtained
DE68905875D1 (de) Anti-hiv-wirkung von bu-3608.
DE69422980D1 (de) Extrakte von Piliostigma thonningii, deren Verwendung und diese enthaltende Zubereitungen
FR2621816B1 (fr) Application antivirale des ologonucleotides
DK595885A (da) Fremgangsmaade og cellelinie til kontinuerlig dannelse af retrovirus(htlv-iii) beslaegtet med aids

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment